From a CFO's desk, the issue is straightforward: a 180-bed multi-specialty hospital in Hyderabad has INR 3.4 crore in claims pending with eight insurers and TPAs. Its oldest claim is 82 days old. The CFO knows where the money is, but equipment vendors want payment, and principal bankers have already been tapped twice this quarter for a working capital overdraft.
This is not financial distress. It is a well-run 180-bed hospital with good occupancy, clean billing, and a payer mix that is 58% insured. The mismatch is structural: Indian insurance payments normally take 90 to 120 days, while operating costs continue.
Healthcare accounts receivable financing addresses this mismatch. This article covers its mechanics, cost, and when it may beat the alternatives.
Why Indian Hospitals Face Payment Delays
IRDAI guidelines require insurers and TPAs to settle cashless claims within 30 days of receiving the final bill, and reimbursement claims within 30 days of receiving all documentation. Actual cycles differ: pre-authorization, document queries, scrutiny holds, and coordination-of-benefits checks can each add days or weeks.
For a patient arriving on day zero, the typical path to cash is: discharge documentation takes two to four days, submission occurs within the first week, TPA scrutiny and queries add two to six weeks, insurer settlement authorization takes one to two weeks, and bank transfer follows within a few days. Straightforward claims take six to eight weeks end-to-end. With scrutiny holds or extra documentation, 90 to 105 days is common.
At 400 insured admissions monthly and an average claim value of INR 45,000, a hospital creates INR 1.8 crore in monthly receivables, unsettled for at least 60 days. It may carry INR 3 to 5 crore in "outstanding but owed" funds that cannot support operations.
AR Financing: What It Is and Isn't
Healthcare AR financing is not a working capital loan. That distinction matters, especially when assessing cost.
A working capital loan is unsecured bank credit based on the borrower's creditworthiness. The hospital receives funds, pays interest on the principal during the term, and repays at maturity. The bank evaluates the hospital's repayment capacity, and prices that entity-level credit risk.
AR financing is asset-based. The collateral is the receivable: a submitted, validated claim documenting an insurer obligation. The provider advances part of its face value, takes assignment of the receivable, and recovers funds when the insurer pays. Risk rests mainly with the insurer's obligation, not the hospital's overall credit profile. Hospitals with limited banking history or used overdraft facilities may therefore still qualify.
For the hospital, AR financing does not appear as balance-sheet debt because it is not a general credit facility. It converts future cash into current cash through a partial sale of the receivable. The hospital records the receivable at full value; the provider holds assignment and recovers the advance and fee when the insurer pays.
How Hospital AR Financing Works
Structures differ, but a typical healthcare AR financing arrangement works like this.
Eligibility: a submitted claim with confirmed TPA or insurer acknowledgment may qualify after a defined wait, typically 14 to 30 days after submission. Claims under formal denial or dispute usually wait until resolution because payment remains uncertain.
Advance rate: the provider typically advances 75 to 85% of face value. It retains 15 to 25% as a reserve if deductions, policy limits, or fee schedule adjustments reduce final settlement.
Funding timeline: after approval, funds reach the hospital account within 24 to 72 hours, depending on the provider. Multiple qualifying claims can produce several lakhs of rupees in one cycle.
Settlement and reconciliation: the insurer pays the provider's designated account, not the hospital. The provider deducts its advance and fee, then sends the balance to the hospital. If payment is lower than submitted, the reserve covers the difference. If paid in full, the hospital receives the full reserve less the financing fee.
Fees vary by provider and payer, but healthcare AR financing in India generally costs 1.5 to 3% of the advance per 30 days, or roughly 18 to 36% per annum on the advanced amount. Compared with bank interest, this sounds high, but the comparison must reflect the capital actually deployed.
Financing Fee vs. Delayed Capital
The economics depend on what the hospital would do with delayed funds and the cost of going without them.
Suppose a INR 2.5 lakh claim receives an 80% advance: INR 2 lakh. At a representative 2% fee for 60 days, the fee is INR 4,000. The hospital gets INR 2 lakh now for INR 4,000.
A bank overdraft at 14% per annum for 60 days on INR 2 lakh costs approximately INR 4,650. The difference is small, but the overdraft uses a capped facility, reducing headroom for other operating needs.
The larger issue is the cost of missing the funds. If a delayed vendor payment incurs a 2% monthly late fee, a INR 2 lakh balance costs approximately INR 4,000 per month. Two months costs about the AR financing fee. If the delay damages the supplier relationship and changes 30-day terms to cash-on-delivery, the indirect cost is much higher.
The useful comparison is specific: what does this gap cost under the hospital's current financing structure and vendor relationships? AR financing can be cost-competitive where overdrafts and vendor delays recur. With clean credit lines and flexible vendors, the pure cost comparison is closer.
When AR Financing Does and Doesn't Fit
AR financing is strongest in three cases: when the working capital facility is already drawn; when the gap involves insured receivables from creditworthy payers, since large national insurers are more predictable than smaller regional operators; and when cash is needed predictably for equipment purchase, a staff salary cycle, or a supplier commitment.
It is less suitable when cheaper working capital is available, when claims carry substantial dispute risk, such as coding queries or scrutiny holds, or when insured revenue is too small to justify the administrative burden of financing.
AR financing cannot replace disciplined revenue cycle management. Chronic denials, documentation gaps, or unresolved billing issues add fees to an inefficient process. First correct submission quality, then finance clean receivables delayed by payer processing rather than billing defects.
Questions for an AR Financing Provider
Before signing, ask any AR financing provider these six questions.
Which payers do you cover? Some providers finance only the five or ten largest national insurers. If 40% of insured volume comes from regional insurers or government schemes, narrow coverage may miss the liquidity need.
What is the advance rate, and does it vary by payer? Rates may reflect insurer creditworthiness: a large national insurer could qualify for 82%, while a smaller TPA gets 70%. Model expectations using the hospital's actual payer mix.
What happens after an insurer underpays? Ask what occurs when settlement is 15% below submission. Does the hospital's reserve take the full shortfall? Does the provider absorb any? Is there recourse?
What are the timely filing requirements? Some providers require submission within a specified window. Delayed billing submissions may therefore reduce coverage.
How are partial payments reconciled? Insurers may pay in several tranches. Clarify the treatment of partial payments and whether the hospital receives anything before full settlement.
What is the exit process? If the hospital stops using the facility, how are open assignments closed? Is notice required, or is there an exit fee?
Provider answers differ, and that matters when a facility covers a material share of monthly insured revenue. Have you checked each against your hospital's payer mix, cash needs, and existing facilities?